Download the Diagnostic and Interventional Cardiology/DAIC Media Kit now to help plan your marketing campaigns for 2024.

 

You’ll get a look at our imaging audience, the editorial calendar, rates and descriptions of all our new and proven products to help you maximize your reach to the complete buying team for interventional cardiology.

December 19, 2023 — A vest that can map the electrical activity of the heart in fine detail could potentially be used to better identify people at high risk of sudden cardiac death, suggests a new study led by UCL researchers.

Electrical signals trigger our hearts to contract, regulating our heartbeat. Problems with these signals result in heart rhythm disorders, experienced by two million people in the UK, and can cause sudden death.

December 19, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, announced that the first patient was enrolled and treated in its CardiALLO Allogeneic Mesenchymal Cell Therapy Phase I/II trial for the treatment of patients with New York Heart Association Class II and III ischemic heart failure of reduced ejection fraction (

December 19, 2023 — Siemens Healthineers announced the Food and Drug Administration (FDA) clearance of the Somatom Pro.Pulse, a dual-source computed tomography scanner designed to be more affordable for a wide range of healthcare facilities, including outpatient diagnostic centers.

December 19, 2023 — Peerbridge Health has announce the successful completion and findings of its prospective, feasibility clinical trial, resulting in a statistically significant 91.2% predictive accuracy for the determination of apnea-hypopnea index (AHI) for diagnosing obstructive sleep apnea (OSA) while using the Peerbridge Cor.

December 18, 2023 — An artificial intelligence (AI) tool developed by investigators at  the 

60th Society of Thoracic Surgeons (STS) Annual Meeting

December 18, 2023 — The Department of Cardiovascular Surgery at The Mount Sinai Hospital has received the highest possible three-star recognition in all of the cardiac surgery categories in the 2020-2023 Society of Thoracic Surgeons (STS) report.

December 18, 2023 — Death rates related to infective endocarditis declined in most adults across the U.S.

December 14, 2023 — Medtronic plc, a global leader in healthcare technology, today announced that the United States Food and Drug Administration (FDA) has approved the PulseSelect Pulsed Field Ablation (PFA) System for the treatment of both paroxysmal and persistent atrial fibrillation (AF).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now